Minimum inhibitory concentration distributions for first- and second-line antimicrobials against Mycobacterium
Rachael M Burke1, Jorge Coronel2, David Moore3,2,1
1Hospital for Tropical Diseases, University College London Hospitals NHS Trust, London, UK.
Abstract:
We report the range of minimum inhibitory concentrations for six antimicrobial drugs in 228 clinical Mycobacterium tuberculosis (MTB) isolates from three distinct groups of patients (unselected patients, patients at high risk of drug-resistant TB and HIV-positive patients) in Lima, Peru. These data highlight the challenges of and discriminatory characteristics required for MTB drug susceptibility testing.
More Related Videos
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
09:57Visualization of the Charcoal Agar Resazurin Assay for Semi-quantitative, Medium-throughput Enumeration of Mycobacteria
Published on: December 14, 2016
Related Concept Videos
Pharmacodynamic Models: Overview
Antimicrobial Effectiveness
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Dosage Interval and Administration Route: Determination Methods
Determination of Multiple Dosing Parameters: Steady-State, Minimum and Maximum Concentrations
